Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRPR | P30550 | 20/20 | 0.87 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1252165 | 1.00 | GRPR (0.87) | GRPR | |
| SCHEMBL1618509 | 0.95 | GRPR (0.85) | GRPR | |
| SCHEMBL1250077 | 0.95 | GRPR (0.85) | GRPR | |
| SCHEMBL1404316 | 0.94 | GRPR (0.78) | GRPR | |
| SCHEMBL1252581 | 0.94 | GRPR (0.86) | GRPR | |
| SCHEMBL1251604 | 0.91 | GRPR (0.86) | GRPR | |
| SCHEMBL1252405 | 0.91 | GRPR (0.86) | GRPR | |
| SCHEMBL1618733 | 0.91 | GRPR (0.86) | GRPR | |
| SCHEMBL16301405 | 0.91 | GRPR (0.83) | GRPR | |
| SCHEMBL1249991 | 0.91 | GRPR (0.86) | GRPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8444954-B2 | Gastrin releasing peptide compounds | BRACCO IMAGING S.P.A. (IT) | 2013-05-21 | — | — | US | disclosed |
| US-20120009122-A1 | GASTRIN RELEASING PEPTIDE COMPOUNDS | BRACCO IMAGING S.P.A. (IT) | 2012-01-12 | — | — | US | disclosed |
| US-7922998-B2 | bombesin, derivatives and/or analogues capable of complexing metal ions, radionuclides or optical labels, for use in radiotherapy | BRACCO IMAGING S.P.A. (IT) | 2011-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120009122-A1 | GASTRIN RELEASING PEPTIDE COMPOUNDS | GRPR, GIPR, CCKBR | GRPR 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.